Calciphylaxis: A systematic review of existing and emerging therapies - 14/11/12
Abstract |
Calciphylaxis, also known as calcific uremic arteriolopathy, is a cutaneous ischemic small vessel vasculopathy seen in 1 to 4% of patients with chronic kidney disease on hemodialysis. It is associated with extreme pain and a 60 to 80% mortality rate in the setting of few and frequently ineffective therapeutic options, although this may be changing based on reports of success with newer therapies.
Le texte complet de cet article est disponible en PDF.Abbreviations used : CKD, FDA, HBO, PTH, STS
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
Vol 67 - N° 6
P. e253-e260 - décembre 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?